name: CDISC360 Pilot 1 CSR
listOfPlannedAnalyses:
  listItems:
  - name: STUDY POPULATION
    order: 1
    sublist:
      listItems:
      - name: Disposition of Subjects
        order: 1
        sublist:
          listItems:
          - name: Summary of Populations
            order: 1
            output: O14-1.01
            sublist:
              listItems:
              - name: Summary by group of All Subjects
                order: 1
                analysis: A9-1.01-01
              - name: Summary of All Subjects
                order: 2
                analysis: A9-1.01-02
              - name: Summary by group of ITT Population
                order: 3
                analysis: A9-1.01-03
              - name: Summary of ITT Population
                order: 4
                analysis: A9-1.01-04
              - name: Summary by group of Safety Population
                order: 5
                analysis: A9-1.01-05
              - name: Summary of Safety Population
                order: 6
                analysis: A9-1.01-06
              - name: Summary by group of Efficacy Population
                order: 7
                analysis: A9-1.01-07
              - name: Summary of Efficacy Population
                order: 8
                analysis: A9-1.01-08
              - name: Summary by group of Completer Week 24 Population
                order: 9
                analysis: A9-1.01-09
              - name: Summary of Completer Week 24 Population
                order: 10
                analysis: A9-1.01-10
              - name: Summary by group of Complete Study Population
                order: 11
                analysis: A9-1.01-11
              - name: Summary of Complete Study Population
                order: 12
                analysis: A9-1.01-12
          - name: Summary of End of Study Data (ITT population)
            order: 2
            output: O14-1.02
            sublist:
              listItems:
              - name: Summary by group of Completion Status
                order: 1
                analysis: A9-1.02-01
              - name: Summary of Completion Status
                order: 2
                analysis: A9-1.02-02
              - name: Summary by group of Reasons for Early Termination
                order: 3
                analysis: A9-1.02-03
              - name: Summary of Reasons for Early Termination
                order: 4
                analysis: A9-1.02-04
              - name: Comparison of Reasons for Study Discontinuation
                order: 5
                analysis: A9-1.02-05
      - name: Demographic and Baseline Characteristics
        order: 2
        sublist:
          listItems:
          - name: Summary of Demographic and Baseline Characteristics (ITT population)
            order: 1
            output: O14-2.01
            sublist:
              listItems:
              - name: Summary by group for continuous variables
                order: 1
                analysis: A9-2.01-01
              - name: Summary for continuous variables
                order: 2
                analysis: A9-2.01-02
              - name: Group comparison for continuous variables
                order: 3
                analysis: A9-2.01-03
              - name: Summary by group for categorical variables
                order: 4
                analysis: A9-2.01-04
              - name: Summary for categorical variables
                order: 5
                analysis: A9-2.01-05
              - name: Group comparison for categorical variables
                order: 6
                analysis: A9-2.01-06
      - name: Treatment Compliance
        order: 3
  - name: EFFICACY ANALYSES
    order: 2
    sublist:
      listItems:
      - name: Primary Efficacy Endpoints
        order: 1
        sublist:
          listItems:
          - name: ADAS-COG (11)
            order: 1
          - name: CIBIC+
            order: 2
      - name: Secondary Efficacy Endpoints
        order: 1
        sublist:
          listItems:
          - name: NPI-X
            order: 1
  - name: SAFETY ANALYSES
    order: 3
    sublist:
      listItems:
      - name: Extent of Exposure
        order: 1
        output: O14-4.01
        sublist:
          listItems:
          - name: Summary by group of Average Daily Dose (Completers at Week 24 Population)
            order: 1
            analysis: A11-1.01-01
          - name: Summary by group of Average Daily Dose (Safety Population)
            order: 1
            analysis: A11-1.01-02
          - name: Summary by group of Cumulative Dose (Completers at Week 24 Population)
            order: 2
            analysis: A11-1.01-03
          - name: Summary by group of Cumulative Dose (Safety Population)
            order: 2
            analysis: A11-1.01-04
      - name: Adverse Events
        order: 2
        sublist:
          listItems:
          - name: Summary of Treatment Emergent Adverse Events
            order: 1
            output: O14-5.01
            sublist:
              listItems:
              - name: Summary by group of Incidence of Treatment Emergent Adverse Events
                order: 1
                analysis: A11-2.01-01
              - name: Placebo to Active Treatment Comparison of Incidence of Treatment Emergent Adverse Events
                order: 2
                analysis: A11-2.01-02
              - name: Summary by group of Incidence of Treatment Emergent Adverse Events by System Organ Class (SOC)
                order: 3
                analysis: A11-2.01-03
              - name: Placebo to Active Treatment Comparison of Incidence of Treatment Emergent Adverse Events by System Organ Class (SOC)
                order: 4
                analysis: A11-2.01-04
              - name: Summary by group of Incidence of Treatment Emergent Adverse Events by Preferred Term (PT)
                order: 5
                analysis: A11-2.01-05
              - name: Placebo to Active Treatment Comparison of Incidence of Treatment Emergent Adverse Events by Preferred Term (PT)
                order: 6
                analysis: A11-2.01-06
          - name: Summary of Dermatological Events
            order: 2
      - name: Deaths and Serious Adverse Events
        order: 3
        sublist:
          listItems:
          - name: Summary of Serious Treatment Emergent Adverse Events
            order: 1
            output: O14-5.02
            sublist:
              listItems:
              - name: Summary by group of Incidence of Serious Treatment Emergent Adverse Events
                order: 1
                analysis: A11-3.01-01
              - name: Placebo to Active Treatment Comparison of Incidence of Serious Treatment Emergent Adverse Events
                order: 2
                analysis: A11-3.01-02
              - name: Summary by group of Incidence of Serious Treatment Emergent Adverse Events by System Organ Class (SOC)
                order: 3
                analysis: A11-3.01-03
              - name: Placebo to Active Treatment Comparison of Incidence of Serious Treatment Emergent Adverse Events by System Organ Class (SOC)
                order: 4
                analysis: A11-3.01-04
              - name: Summary by group of Incidence of Serious Treatment Emergent Adverse Events by Preferred Term (PT)
                order: 5
                analysis: A11-3.01-05
              - name: Placebo to Active Treatment Comparison of Incidence of Serious Treatment Emergent Adverse Events by Preferred Term (PT)
                order: 6
                analysis: A11-3.01-06
      - name: Adverse Events Leading to Discontinuation of Investigational Product and/or Withdrawal from the Study and Other Significant Adverse Events
        order: 4
      - name: Clinical Laboratory Evaluations
        order: 5
      - name: Other Safety Measures
        order: 6
        sublist:
          listItems:
          - name: Vital Signs
            order: 1
            sublist:
              listItems:
              - name: Summary of Vital Signs at Baseline and End of Treatment
                order: 1           
                analysis: A11-6.01-01
                output: O14-7.01
              - name: Summary of Vital Signs Change from Baseline at End of Treatment
                order: 2
                analysis: A11-6.01-02
                output: O14-7.02
          - name: Concomitant Medications
            order: 2
            sublist:
              listItems:
              - name: Summary of Concomitant Medications (Number of Subjects)
                order: 1           
                analysis: A11-6.02-01
                output: O14-7.04
analysisSets:
- id: AnalysisSet_01
  label: Intent-to-Treat Population
  order: 1
  condition:
    dataset: ADSL
    variable: ITTFL
    comparator: EQ
    value:
    - Y
- id: AnalysisSet_02
  label: Safety Population
  order: 1
  condition:
    dataset: ADSL
    variable: SAFFL
    comparator: EQ
    value:
    - Y
- id: AnalysisSet_03
  label: Efficacy Population
  order: 1
  condition:
    dataset: ADSL
    variable: EFFFL
    comparator: EQ
    value:
    - Y
- id: AnalysisSet_04
  label: Completer Week 24 Population
  order: 1
  condition:
    dataset: ADSL
    variable: COMP24FL
    comparator: EQ
    value:
    - Y
- id: AnalysisSet_05
  label: Complete Study Population
  order: 1
  condition:
    dataset: ADSL
    variable: DISCONFL
    comparator: NE
    value:
    - Y
analysisGroupings:
- id: AnlsGrouping_01_Sex
  label: Sex
  dataDriven: false
  groupingVariable: SEX
  groups:
  - id: AnlsGrouping_01_Sex_1
    label: Male
    order: 1
    condition: 
      dataset: ADSL
      variable: SEX
      comparator: EQ
      value:
      - M
  - id: AnlsGrouping_01_Sex_2
    label: Female
    order: 2
    condition: 
      dataset: ADSL
      variable: SEX
      comparator: EQ
      value:
      - F
- id: AnlsGrouping_02_Trt
  label: Treatment
  dataDriven: false
  groupingVariable: TRT01A
  groups:
  - id: AnlsGrouping_02_Trt_1
    label: Placebo
    order: 1
    condition: 
      dataset: ADSL
      variable: TRT01A
      comparator: EQ
      value:
      - Placebo
  - id: AnlsGrouping_02_Trt_2
    label: Xanomeline Low Dose
    order: 2
    condition: 
      dataset: ADSL
      variable: TRT01A
      comparator: EQ
      value:
      - Xanomeline Low Dose
  - id: AnlsGrouping_02_Trt_3
    label: Xanomeline High Dose
    order: 3
    condition: 
      dataset: ADSL
      variable: TRT01A
      comparator: EQ
      value:
      - Xanomeline High Dose
dataSubsets:
- id: DataSubset_01
  label: Treatment-Emergent Adverse Events
  condition:
    dataset: ADAE
    variable: TRTEMFL
    comparator: EQ
    value:
    - Y
analysisCategorizations:
- id: AnCat1_Group
  label: Group of Analyses
  categories:
  - id: AnCat1_Group_PopDesc
    label: Population Description
  - id: AnCat1_Group_Safety
    label: Safety Analyses
  - id: AnCat1_Group_Efficacy
    label: Efficacy Analyses
- id: AnCat2_Class
  label: Analysis Data Class
  categories:
  - id: AnCat2_Class_SubjLvl
    label: Subject-level
    subCategorizations:
    - id: AnCat2.1_SbjDType
      label: Subject-level Data Type
      categories:
      - id: AnCat2.1_SbjDType_Demo
        label: Demographics
  - id: AnCat3_Class_Events
    label: Events
    subCategorizations:
    - id: AnCat3.1_EvtDType
      label: Event Data Type
      categories:
      - id: AnCat3.1_EvtDType_AE
        label: Adverse Events
      - id: AnCat3.1_EvtDType_CE
        label: Clinical Events
      - id: AnCat3.1_EvtDType_Disp
        label: Disposition
    - id: AnCat3.2_EvtAType
      label: Event Analysis Type
      categories:
      - id: AnCat3.2_EvtAType_Occ
        label: Occurrence
      - id: AnCat3.2_EvtAType_TTE
        label: Time-to-Event
  - id: AnCat4_Class_Findings
    label: Findings
    subCategorizations:
    - id: AnCat4.1_FndDType
      label: Findings Data Type
      categories:
      - id: AnCat4.1_FndDType_Vitals
        label: Vital Sign
      - id: AnCat4.1_FndDType_Labs
        label: Laboratory Tests
    - id: AnCat4.2_FndAType
      label: Findings Analysis Type
      categories:
      - id: AnCat4.2_FndAType_Chg
        label: Change from Baselines
      - id: AnCat4.2_FndAType_Shft
        label: Shift Table
- id: AnCat5_EstAType
  label: Estimand Analysis Type
  categories:
  - id: AnCat5_EstAType_Prim
    label: Primary Estimator
  - id: AnCat5_EstAType_Sens
    label: Sensitivity Analysis
  - id: AnCat5_EstAType_Supp
    label: Supplementary Analysis
analyses:
- id: A9-1.01-01
  version: 1
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  dataset: ADSL
  categoryRefs:
  - AnCat1_Group_PopDesc
  - AnCat2_Class_SubjLvl
  - AnCat2.1_SbjDType_Demo
- id: A9-1.01-02
  version: 1 
- id: A9-1.01-03
  version: 1
  analysisSet: AnalysisSet_01
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  dataset: ADSL
- id: A9-1.01-04
  version: 1
  analysisSet: AnalysisSet_01
  dataset: ADSL
- id: A9-1.01-05
  version: 1
  analysisSet: AnalysisSet_02
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  dataset: ADSL
- id: A9-1.01-06
  version: 1
  analysisSet: AnalysisSet_02
  dataset: ADSL
- id: A9-1.01-07
  version: 1
  analysisSet: AnalysisSet_03
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  dataset: ADSL
- id: A9-1.01-08
  version: 1
  analysisSet: AnalysisSet_03
  dataset: ADSL
- id: A9-1.01-09
  version: 1
  analysisSet: AnalysisSet_04
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  dataset: ADSL
- id: A9-1.01-10
  version: 1
  analysisSet: AnalysisSet_04
  dataset: ADSL
- id: A9-1.01-11
  version: 1
  analysisSet: AnalysisSet_05
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  dataset: ADSL
- id: A9-1.01-12
  version: 1
  analysisSet: AnalysisSet_05
  dataset: ADSL
- id: A9-1.02-02
  version: 1
  analysisSet: AnalysisSet_05
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  - order: 2
    dataGrouping:
      id: DataGrouping_01_RDC-DD
      label: Reason for Discontinuation
      dataDriven: true
      groupingVariable: DCREASCD
  dataset: ADSL
- id: A9-1.02-03
  version: 1
  analysisSet: AnalysisSet_05
  orderedGroupings:
  - order: 1
    groupingRef: DataGrouping_01_RDC-DD
  dataset: ADSL
- id: A9-1.02-04
  version: 1
  analysisSet: AnalysisSet_05
  orderedGroupings:
  - order: 1
    groupingRef: AnlsGrouping_02_Trt
  - order: 2
    dataGrouping:
      id: DataGrouping_01_RDC
      label: Reason for Discontinuation
      dataDriven: false
      groupingVariable: DCREASCD
      groups:
      - id: DataGrouping_01_RDC_1
        label: Completed
        order: 1
        condition: 
          dataset: ADSL
          variable: DCREASCD
          comparator: EQ
          value:
          - Completed
      - id: DataGrouping_01_RDC_2
        label: Adverse Event
        order: 2
        condition: 
          dataset: ADSL
          variable: DCREASCD
          comparator: EQ
          value:
          - Adverse Event
      - id: DataGrouping_01_RDC_3
        label: Lack of Efficacy
        order: 3
        condition: 
          dataset: ADSL
          variable: DCREASCD
          comparator: EQ
          value:
          - Lack of Efficacy
  dataset: ADSL
globalDisplaySections:
- sectionType: Title
  subSections:
  - id: Global_ID_001-01
    order: 1
    text: "CDISC360 Pilot 1"
- sectionType: Footnote
  subSections:
  - id: Global_ID_001-02
    order: 1
    text: "Program: <pid>.sas, Output: <pid><oid>.rtf, Generated on: &outdate9.:&outtime."
outputs:
- id: O14-1.01
  version: 1
  fileSpecifications:
  - name: O-14-01-01-pop
    fileType: rtf
    location: .
    style: To be defined
  categoryRefs:
  - AnCat1_Group_PopDesc
  - AnCat2_Class_SubjLvl
  - AnCat2.1_SbjDType_Demo
  outputDisplays:
  - order: 1
    display: 
      id: T14101-POP
      name: Table 14-1.01
      version: 1
      displayTitle: Summary of Populations
      displaySections:
      - sectionType: Title
        subSections:
        - id: T14101-POP-DISP-01
          order: 1
          text: "Table 14-1.01 Summary of Populations"
        - id: T14101-POP-DISP-02
          order: 2
          text: "Population: All Subjects"
        - Global_ID_001-01:
            order: 3
      - sectionType: Legend
        subSections:
        - id: T14101-POP-DISP-03
          order: 1
          text: "NOTE: N in column headers represents number of subjects entered in study (i.e., signed informed consent). The ITT population includes all subjects randomized. The Safety population includes all randomized subjects known to have taken at least one dose of randomized study drug. The Efficacy population includes all subjects in the safety population who also have at least one post-baseline ADAS-Cog and CIBIC+ assessment"
      - sectionType: Footnote
        subSections:
        - id: T14101-POP-DISP-03
          order: 1
          text: "Source dataset: adsl, Generated on: &dsdate9.:&dstime."
        - id: T14101-POP-DISP-06
          order: 2
          text: "Program: T-pop-all.sas, Output: O-14-01-01-pop.rtf, Generated on: &outdate9.:&outtime."
      - sectionType: Rowlabel Header
        subSections:
        - id: T1420-1-DEMOG-DISP-07
          order: 1
          text: "Population"
- id: O14-1.02
  version: 1
  fileSpecifications:
  - name: O-14-01-02-demog
    fileType: rtf
    location: .
    style: To be defined
  outputDisplays:
  - order: 1
    display: 
      id: T14102-DEMOG
      name: Table 14.1.2
      version: 1
      displayTitle: Summary of Demographics and Baseline Characteristics - Safety
      displaySections:
      - sectionType: Title
        subSections:
        - id: T1420-1-DEMOG-DISP-01
          order: 1
          text: "Table 14.2.01 Summary of Demographics and Baseline Characteristics"
        - id: T1420-1-DEMOG-DISP-02
          order: 2
          text: "Safety Population"
        - Global_ID_001-01:
            order: 3
      - sectionType: Legend
        subSections:
        - id: T1420-1-DEMOG-DISP-03
          order: 1
          text: "[1] P-values are results of ANOVA treatment group comparisons for continuous variables and Pearsonâ€™s chisquare test for categorical variables."
        - id: T1420-1-DEMOG-DISP-04
          order: 2
          text: "NOTE: Duration of disease is computed as months between date of enrollment and date of onset of the first definite symptoms of Alzheimer's disease."
      - sectionType: Footnote
        subSections:
        - id: T1420-1-DEMOG-DISP-05
          order: 1
          text: "Source dataset: adsl, Generated on: &dsdate9.:&dstime."
        - id: T1420-1-DEMOG-DISP-06
          order: 2
          text: "Program: T-demog-saf.sas, Output: T-14-01-02-01-demog-saf.rtf, Generated on: &outdate9.:&outtime."
      - sectionType: Rowlabel Header
        subSections:
        - id: T1420-1-DEMOG-DISP-07
          order: 1
          text: "Characteristics"
- id: O14-5.01
  version: 1
  fileSpecifications:
  - name: O-14-05-01-aesum
    fileType: rtf
    location: .
    style: To be defined
  outputDisplays:
  - order: 1
    display:
      id: T14501-AE-SUMM
      name: Table 14.5.1
      version: 1
      displayTitle: Overall Summary of Treatment-Emergent Adverse Events
      displaySections:
      - sectionType: Title
        subSections:
        - id: T14301-AE-SUMM-DISP-01
          order: 1
          text: "Table 14-5.01"
        - id: T14301-AE-SUMM-DISP-02
          order: 2
          text: "Incidence of Treatment Emergent Adverse Events by Treatment Group"
        - T14701-VITALS-CHGBL-DISP-03:
            order: 3
      - sectionType: Legend
        subSections:
        - id: T14501-AE-SUMM-DISP-04
          order: 1
          text: "Note: TEAE=Treatment-Emergent Adverse Events"
        - id: T14501-AE-SUMM-DISP-05
          order: 2
          text: "Note: Treatment emergent events are defined as events which start on or after the start of treatment."
        - id: T14501-AE-SUMM-DISP-06
          order: 3
          text: "Note: Adverse events are coded using MedDRA."
        - id: T14501-AE-SUMM-DISP-07
          order: 4
          text: "Note: Percentages are based on the number of subjects in the safety population within each treatment group."
        - id: T14501-AE-SUMM-DISP-08
          order: 5
          text: "Note: P-values are based on Fisher's Exact test for the comparison of placebo versus each active treatment group. An asterisk is appended to p-values that are less than 0.15."
        - id: T14501-AE-SUMM-DISP-09
          order: 6
          text: "Note: The column [AE] represents the total number of times an event was recorded."
      - sectionType: Footnote
        subSections:
        - id: T14501-AE-SUMM-DISP-10
          order: 1
          text: 'Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\aetable.sas, Generated on: &outdate9.:&outtime.'
      - sectionType: Rowlabel Header
        subSections:
        - id: T14501-AE-SUMM-DISP-08
          order: 1
          text: "System Organ Class/Preferred Term"
- id: O14-7.01
  version: 1
  fileSpecifications:
  - name: O-14-07-01-vitals-summ
    fileType: rtf
    location: .
    style: To be defined
  outputDisplays:
  - order: 1
    display: 
      id: T14701-VITALS-SUMM
      name: Table 14-7.01
      displayTitle: Summary of Vital Signs at Baseline and End of Treatment
      displaySections:
      - sectionType: Title
        subSections:
        - id: T14701-VITALS-SUMM-DISP-01
          order: 1
          text: "Table 14-7.01"
        - id: T14701-VITALS-SUMM-DISP-02
          order: 2
          text: "Summary of Vital Signs at Baseline and End of Treatment"
        - id: T14701-VITALS-SUMM-DISP-03
          order: 3
          text: "Safety Population"
      - sectionType: Legend
        subSections:
        - id: T14701-VITALS-SUMM-DISP-04
          order: 1
          text: "End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 visit)."
      - sectionType: Footnote
        subSections:
        - id: T14701-VITALS-SUMM-DISP-05
          order: 1
          text: 'Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas, Generated on: &outdate9.:&outtime.'
      - sectionType: Rowlabel Header
        subSections:
        - id: T14701-VITALS-SUMM-DISP-06
          order: 1
          text: "Measure"
        - id: T14701-VITALS-SUMM-DISP-07
          order: 2
          text: "Position"
        - id: T14701-VITALS-SUMM-DISP-08
          order: 3
          text: "Treatment"
        - id: T14701-VITALS-SUMM-DISP-09
          order: 4
          text: "N"
        - id: T14701-VITALS-SUMM-DISP-10
          order: 5
          text: "Planned Relative Time"
- id: O14-7.02
  version: 1
  fileSpecifications:
  - name: O-14-07-02-vitals-chgbl
    fileType: rtf
    location: .
    style: To be defined
  outputDisplays:
  - order: 1
    display: 
      id: T14702-VITALS-CHGBL
      name: Table 14-7.02
      displayTitle: Summary of Vital Signs Change from Baseline at End of Treatment
      displaySections:
      - sectionType: Title
        subSections:
        - id: T14702-VITALS-CHGBL-DISP-01
          order: 1
          text: "Table 14-7.02"
        - id: T14702-VITALS-CHGBL-DISP-02
          order: 2
          text: "Summary of Vital Signs Change from Baseline at End of Treatment"
        - id: T14702-VITALS-CHGBL-DISP-03
          order: 3
          text: "Safety Population"
      - sectionType: Legend
        subSections:
        - id: T14702-VITALS-CHGBL-DISP-04
          order: 1
          text: "End of treatment is the last on-treatment assessment of the specified vital sign (on or before the Week 24 visit)."
      - sectionType: Footnote
        subSections:
        - id: T14702-VITALS-CHGBL-DISP-05
          order: 1
          text: 'Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtvs.sas, Generated on: &outdate9.:&outtime.'
      - sectionType: Rowlabel Header
        subSections:
        - id: T14702-VITALS-CHGBL-DISP-06
          order: 1
          text: "Measure"
        - id: T14702-VITALS-CHGBL-DISP-07
          order: 2
          text: "Position"
        - id: T14702-VITALS-CHGBL-DISP-08
          order: 3
          text: "Treatment"
        - id: T14702-VITALS-CHGBL-DISP-09
          order: 4
          text: "N"
        - id: T14702-VITALS-CHGBL-DISP-10
          order: 5
          text: "Planned Relative Time"
